Rakhi Kilaru - Concepedia

Author

Rakhi Kilaru

Clinical Research Institute

Also Known As

Kilaru, R, R Kilaru, R. Kilaru, Rakhi Kilaru

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Clinical Research Institute Duke Medical Center Brigham and Women's Hospital Duke University Wilhelminen Hospital

About

Rakhi Kilaru is an author at Clinical Research Institute specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	504
2	Emergency Medicine	4	4	291
3	Public Health	1	1	27
4	Biochemistry	1	1	23
5	Diabetes	1	1	27

Rakhi Kilaru

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome John H. Alexander, Renato D. Lópes, Stefan James, New England Journal of Medicine	2011	994
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: Lessons from 4 international fibrinolytic therapy trials David Hasdai, Eric J. Topol, Rakhi Kilaru, American Heart Journal ThrombosisSt-segment ElevationHeart FailureCardiovascular DiseaseMedicine	2003	101
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial Jeffrey S. Berger, Matthew T. Roe, C. Michael Gibson, American Heart Journal ThrombosisPercutaneous Coronary InterventionPlatelet ThrombosisCardiovascular DiseaseBlood Platelet	2009	100
Is the Extrapolated Adult Dose of Fosinopril Safe and Effective in Treating Hypertensive Children? Jennifer S. Li, Katherine Berezny, Rakhi Kilaru, Hypertension Fosinopril SafeHigh-normal Blood PressureHypertensionNon-pharmacological InterventionCardiovascular Disease	2004	69
Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry) Jonathan P. Piccini, Patrick Hranitzky, Rakhi Kilaru, The American Journal of Cardiology Heart FailureCardiovascular DiseaseCardiovascular PharmacologySustained Ventricular TachycardiaPharmacotherapy	2008	68
Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting Marino Labinaz, Rakhi Kilaru, Karen S. Pieper, Circulation	2002	63
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Laura S. Fernandes, James E. Tcheng, J.Conor O’Shea, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseGlycoprotein Iib/iiia AntagonismPharmacology	2002	58
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry Karolina Szummer, Scott D. Solomon, Eric J. Velazquez, European Heart Journal	2005	39
Racial differences are seen in blood pressure response to fosinopril in hypertensive children Sharad Menon, Katherine Berezny, Rakhi Kilaru, American Heart Journal HypertensionCardiovascular DiseaseRacial DifferencesAntihypertensive TherapyPhysiology	2006	36
Intravenous Synthetic Secretin Reduces the Incidence of Pancreatitis Induced by Endoscopic Retrograde Cholangiopancreatography Paul S. Jowell, M. Stanley Branch, Seymour Fein, Pancreas	2011	27

Page 1